Large gap with delayed quotes
|
Last quote
04/25/2026
-
02:00:00
|
Bid
04/27/2026 -
14:56:26
|
Bid Volume |
Ask
04/27/2026 -
14:56:26
|
Ask Volume |
|---|---|---|---|---|
|
28.58
-0.33
(
-1.14% )
|
25.94
|
100 |
28.77
|
100 |
Analysis date: 24.04.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 14.04.2026.
Interest
Strong
Strong
Three stars since 14.04.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 31.03.2026 at a price of 24.84.
Evaluation
Strongly overvalued
Strongly overvalued
Based on its growth potential and our own criteria, we believe the share price is currently overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 14.04.2026.
4wk Rel Perf
10.60%
10.60%
The four-week dividend-adjusted overperformance versus SP500 is 10.60%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 10.04.2026.
Bear Market Factor
Low
Low
On average, the stock has a tendency to minimize the drops in the index by -0.22%.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.27%.
Mkt Cap in $bn
5.82
5.82
With a market capitalization between $2 & $8bn, IMMUNOVANT is considered a mid-cap stock.
G/PE Ratio
-0.14
-0.14
A negative ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) indicates that either the forecasted growth is decelerating (negative annualized growth estimate) or the financial analysts are expecting a loss (negative estimated PE).
LT P/E
-16.77
-16.77
The estimated PE is negative: the financial analysts' earnings estimates forecast a loss.
LT Growth
-2.28%
-2.28%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
143
143
For 1% of index variation, the stock varies on average by 1.43%.
Correlation
0.33
0.33
Stock movements are strongly independent of index variations.
Value at Risk
6.86
6.86
The value at risk is estimated at USD 6.86. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
01.12.2023
01.12.2023